Compare CTRE & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTRE | EMN |
|---|---|---|
| Founded | 2013 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Major Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 8.1B |
| IPO Year | 2013 | 1996 |
| Metric | CTRE | EMN |
|---|---|---|
| Price | $41.67 | $68.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $42.40 | ★ $79.31 |
| AVG Volume (30 Days) | ★ 3.0M | 1.1M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | 3.44% | ★ 4.77% |
| EPS Growth | ★ 96.25 | N/A |
| EPS | 0.36 | ★ 0.93 |
| Revenue | $476,393,000.00 | ★ $8,752,000,000.00 |
| Revenue This Year | $5.97 | $3.06 |
| Revenue Next Year | $13.39 | $3.47 |
| P/E Ratio | $116.01 | ★ $74.03 |
| Revenue Growth | ★ 60.79 | N/A |
| 52 Week Low | $30.21 | $56.11 |
| 52 Week High | $43.08 | $83.47 |
| Indicator | CTRE | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 66.39 | 41.85 |
| Support Level | $35.82 | $66.33 |
| Resistance Level | $41.86 | $71.34 |
| Average True Range (ATR) | 0.98 | 2.16 |
| MACD | 0.50 | -0.48 |
| Stochastic Oscillator | 98.53 | 25.70 |
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.